Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead ...

Moderna's Phase 1/2 study shows mRNA-4359 plus pembrolizumab yields 24% response rate and 60% disease control in resistant ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Moderna is producing its first made-in-Canada COVID-19 shots at facilities in Laval, Que. and Cambridge, Ont. The Laval ...

Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD treatment was rejected by an FDA advisory committee. Pfizer's PD-1xVEGF deal ...

Moderna said on Thursday it would trim roughly 10 per cent of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid ...

Moderna has opened its new vaccine manufacturing and R&D facility in Oxfordshire, UK, the Moderna Innovation and Technology Centre (MITC).

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

Vaccine-maker Moderna has opened a new manufacturing base in Oxfordshire in a boost to the pharmaceutical industry after other major firms shelved or paused planned UK investments this year. The ...

Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...

UK finance minister Rachel Reeves told reporters that the country needs to be an attractive place for pharma, including in ...